Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patient willing to give voluntary informed consent,affected patient must follow two out of three criteria of Rotterdam(ASRM/ESHRM):- 1)Oligo and/or anovulation 2)Hyperandrogenism(clinical/biochemical) 3)Polycystic ovaries(confirmed or USG)
Exclusion criteria
Exclusion criteria: Age below 18 and above 40 years patients with chronic systemic illness(cardiac failure,cirrhosis of liver,hypertension,diabetes mellitus tuberculosis,chronic renal disease) patient having reproductive system abnormalities(excluded clinically and radiologically,hydrosalpinx,endometrosis,adenomyosis,carcinoma of reproductive organ)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in graffian follicle count,ovarian volume,ovarian stromaTimepoint: duration of trial will be of 33 days,follow up after 3months | — |
Secondary
| Measure | Time frame |
|---|---|
| normalised LH:FSH(1:2) ratio, regular menstrual cycle,reduction in weight,BMI and acne areaTimepoint: duration of trial will be of 33 days,follow up after 3months | — |
Countries
India
Contacts
SHRI KRISHNA GOVT. AYURVEDIC COLLEGE AND HOSPITAL KURUKSHTRA